NDC 51672-4083-01 - Hydrocortisone Butyrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4083
- Requested NDC
- 51672-4083-01
- Package NDCs from labels
- 51672-4083-5, 51672-4083-7, 51672-4083-1, 51672-4083-2, 51672-4083-6, 51672-4083-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrocortisone Butyrate Ointment, 0.1% Hydrocortisone Butyrate Cream USP, 0.1% Hydrocortisone Butyrate Topical Solution, 0.1% | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4083-1 | Hydrocortisone Butyrate | 15 g in 1 TUBE | OINTMENT | 15 | 5 | |
| 51672-4083-1 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-2 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-2 | Hydrocortisone Butyrate | 30 g in 1 TUBE | OINTMENT | 30 | 5 | |
| 51672-4083-5 | Hydrocortisone Butyrate | 5 g in 1 TUBE | OINTMENT | 5 | 5 | |
| 51672-4083-6 | Hydrocortisone Butyrate | 45 g in 1 TUBE | OINTMENT | 45 | 5 | |
| 51672-4083-6 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-7 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-7 | Hydrocortisone Butyrate | 10 g in 1 TUBE | OINTMENT | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4083 | HYDROCORTISONE BUTYRATE SOLUTION HYDROCORTISONE BUTYRATE CREAM HYDROCORTISONE BUTYRATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 9 package rows | 20210409_51176835-598d-4da7-8a00-6bd36f52aa82.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4083-1 | GM - Gram | 51672-4083 | efb8d4d9-57f2-4954-890a-9738be50e6ed | 1 | 2012-07-24 |
| 51672-4083-6 | GM - Gram | 51672-4083 | 146e42f8-c9cd-4fa2-b41a-089bcca3cb99 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Walgreens 70% Isopropyl Alcohol Wipes | ISOPROPYL ALCOHOL | Walgreen Company | e8b0ecc3-3a30-47c9-b7d1-518681d575b4 | 2026-05-21 | Warnings | ND2M416302 |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 8e255bc7-a120-460a-a32d-43931f8115de | 2026-05-21 | Warnings, Adverse reactions | 2968PHW8QP B22547B95K |
| CeraVe Developed with Dermatologists Healing Lip Balm | PETROLATUM | L'Oreal USA Products Inc | 21dc8842-0672-4d46-bcea-b8e3d54c48bf | 2026-05-20 | Warnings | 4T6H12BN9U |
| 70% Isopropyl Alcohol | 70% ISOPROPYL ALCOHOL | Greatdealson, Inc. | 4aa809cd-500a-dd65-e063-6394a90a3144 | 2026-05-20 | Warnings, Adverse reactions | ND2M416302 |
| WHITENING SUNSCREENANTI WRINKLE | WHITENING SUNSCREENANTI WRINKLE | Shantou Oushiya Biotechnology Co.,Ltd | 524384e9-b3f8-4c13-e063-6394a90a8973 | 2026-05-20 | Warnings | 059QF0KO0R |
| CVS Isopropyl Rubbing Alcohol Wipes | ISOPROPYL ALCOHOL | CVS PHARMACY, INC | 7e027210-9729-4659-8a75-b6b2ac60f7bc | 2026-05-19 | Warnings | ND2M416302 |
| CVS Isopropyl Rubbing Alcohol Pads | ISOPROPYL ALCOHOL | CVS PHARMACY, INC | e65b3363-71d9-47b6-a044-edac18f9858f | 2026-05-19 | Warnings | ND2M416302 |
| Wish Alcohol Pad | ISOPROPYL ALCOHOL CLOTH | Yiwu Ori-Power Medtech Co.,Ltd. | 51f87ed7-04ae-136a-e063-6294a90a9500 | 2026-05-16 | Warnings | ND2M416302 |
| Alcohol prep pad | ISOPROPYL ALCOHOL CLOTH | Hubei V-Medical Products co.,Ltd. | 51d5780e-9039-1b66-e063-6394a90a0b8a | 2026-05-15 | Warnings | ND2M416302 |
| Verifine Alcohol Swabs | ALCOHOL SWABS | Promisemed Hangzhou Meditech Co.,LTD. | 4e91983f-4570-3a56-e063-6394a90a38f2 | 2026-05-15 | Warnings | ND2M416302 |
| REFRESH LACRI-LUBE | MINERAL OIL, PETROLATUM | Allergan, Inc. | d232a44b-516d-4cdf-a4e7-c3a9a50dc7af | 2026-05-15 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Cerave Developed with Dermatologists Healing | PETROLATUM | LOreal USA Products Inc | de44ac01-ba17-4f97-ac12-9ea348013bde | 2026-05-14 | Warnings | 4T6H12BN9U |
| Swab Applicator Brushes 2% w/w chlorhexidine gluconate (CHG) and 70% v/v isopropyI alcohol (IPA) | CHLORHEXIDINE GLUCONATE, ISOPROPYI ALCOHOL | XINXIANG XINDA TECHNOLOGY CO.,LTD | 51c34af0-2b12-c5e0-e063-6394a90a4174 | 2026-05-14 | Warnings | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Chain Drug Marketing Association | f5b99c4b-1f4b-40be-bae7-59aa92c5b52c | 2026-05-14 | Warnings, Adverse reactions | ND2M416302 |
| HEMORRHOIDAL WITH LIDOCAINE | GLYCERIN, LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE, WHITE PETROLATUM | CVS PHARMACY, INC | 4d870c68-9e72-464e-b0b8-900d0d661e43 | 2026-05-14 | Warnings | PDC6A3C0OX |
| 91% Isopropyl Alcohol | ISOPROPYL ALCOHOL | Chain Drug Marketing Association | f10995fd-fe94-436a-8783-4cdf10438d75 | 2026-05-14 | Warnings, Adverse reactions | ND2M416302 |
| 70% Isopropyl Alcohol | ISOPROPYL ALCOHOL | Chain Drug Marketing Association | c07b7f1b-eda2-4f0f-a35d-f34ac85abab3 | 2026-05-14 | Warnings, Adverse reactions | ND2M416302 |
| Isopropyl alcohol | ISOPROPYL ALCOHOL | HARRIS TEETER | b3fa1454-25cd-4801-bbec-5da43a70ec7f | 2026-05-14 | Warnings | ND2M416302 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | HARRIS TEETER | c4e816c7-a8a2-404c-9354-eaaed6dbf0f5 | 2026-05-14 | Warnings | ND2M416302 |
| Evesse | HYDROCORTISONE BUTYRATE | Perfero Pharma, Inc. | 988b5524-2947-4862-9d5b-e8b7fec5fd9a | 2026-05-14 | Warnings, Adverse reactions | 05RMF7YPWN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.